International Patient Access

What is the International Patient Access Standard?

The International Patient Access (IPA) standard is the emerging global specification that empowers patients by allowing medical apps to easily access and share health information across countries. It builds upon existing FHIR® (Fast Healthcare Interoperability Resources) standards but adds important improvements for secure, reliable, and consistent data exchange.

Key Features of IPA:

IPA uses FHIR profiles (specifications for how specific data is structured) to define a globally harmonized set of core health information. Countries can then expand on this base information to meet their unique needs.

Learn More:

You can find more details on the IPA 1.0 specification and related resources. Stay updated on the latest IPA developments by visiting our blog and joining the HL7® community.

Who is driving the IPA project?

The IPA initiative is driven by HL7 International, a not-for-profit organization dedicated to developing standards for the exchange of electronic health information. As a global leader in health data interoperability, HL7’s work is largely made possible through the contributions of volunteers from various sectors in the healthcare and technology industries.

Participating Organizations and Individuals:

  • Healthcare Providers: Hospitals, clinics, and healthcare networks around the globe contribute insights and testing environments.
  • Technology Companies: Leaders in health IT who provide expertise in software and systems integration.
  • Government Health Agencies: Ensuring regulations and standards are met across different countries.
  • Academic Institutions: Conducting research and providing expert analyses and recommendations.
  • Dedicated Individuals: Volunteers from all backgrounds, including doctors, nurses, IT professionals, and policymakers, who bring diverse perspectives and skills to the table.

The collaboration among these entities exemplifies the commitment to improving global health data interoperability and ensuring patients have greater access and control over their healthcare information.

HL7®, and FHIR® are the registered trademarks of Health Level Seven International and their use of these trademarks does not constitute an endorsement by HL7.

FAQs